Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 35876 - 35900 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Doxorubicin	Approved Investigational	COL12A1	1303	downregulated	Doxorubicin results in decreased expression of COL12A1 mRNA	6q13-q14.1	A22430
Doxorubicin	Approved Investigational	COQ8A	56997	upregulated	Doxorubicin results in increased expression of COQ8A mRNA	1q42.13	A22426
Doxorubicin	Approved Investigational	CORIN	10699	downregulated	Doxorubicin results in decreased expression of CORIN mRNA	4p12	A21904
Doxorubicin	Approved Investigational	CRISP2	7180	downregulated	Doxorubicin results in decreased expression of CRISP2 mRNA	6p12.3	A22426
Doxorubicin	Approved Investigational	CSPG4	1464	upregulated	Doxorubicin results in increased expression of CSPG4 mRNA	15q24.2	A22426
Doxorubicin	Approved Investigational	CTGF	1490	upregulated	Doxorubicin results in increased expression of CTGF mRNA	6q23.2	A22424
Doxorubicin	Approved Investigational	CXCL6	6372	downregulated	Doxorubicin results in decreased expression of CXCL6 mRNA	4q13.3	A22426
Doxorubicin	Approved Investigational	CXCL8	3576	downregulated	Doxorubicin results in decreased expression of CXCL8 mRNA	4q13.3	A22443
Doxorubicin	Approved Investigational	CXCL8	3576	upregulated	Doxorubicin results in increased expression of CXCL8 mRNA	4q13.3	A22419
Doxorubicin	Approved Investigational	CYC1	1537	upregulated	Doxorubicin results in increased expression of CYC1 mRNA	8q24.3	A21894
Doxorubicin	Approved Investigational	CYCS	54205	upregulated	Doxorubicin results in increased expression of CYCS mRNA	7p15.3	A21894 A22441
Doxorubicin	Approved Investigational	CYP27B1	1594	upregulated	Doxorubicin results in increased expression of CYP27B1 mRNA	12q14.1	A22454
Doxorubicin	Approved Investigational	DEK	7913	upregulated	Doxorubicin results in increased expression of DEK mRNA	6p22.3	A22424
Doxorubicin	Approved Investigational	DGKI	9162	downregulated	Doxorubicin results in decreased expression of DGKI mRNA	7q33	A22426
Doxorubicin	Approved Investigational	DHPS	1725	upregulated	Doxorubicin results in increased expression of DHPS mRNA	19p13.13	A22426
Doxorubicin	Approved Investigational	DIABLO	56616	upregulated	Doxorubicin results in increased expression of DIABLO mRNA	12q24.31	A22442
Doxorubicin	Approved Investigational	DKK2	27123	downregulated	Doxorubicin results in decreased expression of DKK2 mRNA	4q25	A22426
Doxorubicin	Approved Investigational	DMD	1756	downregulated	Doxorubicin results in decreased expression of DMD mRNA	Xp21.2-p21.1	A21904
Doxorubicin	Approved Investigational	DNAJA1	3301	upregulated	Doxorubicin results in increased expression of DNAJA1 mRNA	9p21.1	A22424
Doxorubicin	Approved Investigational	DSPP	1834	downregulated	Doxorubicin results in decreased expression of DSPP mRNA	4q22.1	A22426
Doxorubicin	Approved Investigational	DUSP4	1846	upregulated	Doxorubicin results in increased expression of DUSP4 mRNA	8p12	A21904
Doxorubicin	Approved Investigational	E2F1	1869	downregulated	Doxorubicin results in decreased expression of E2F1 mRNA	20q11.22	A22433
Doxorubicin	Approved Investigational	EP300	2033	downregulated	Doxorubicin results in decreased expression of EP300 mRNA	22q13.2	A21498
Doxorubicin	Approved Investigational	EPHA2	1969	upregulated	Doxorubicin results in increased expression of EPHA2 mRNA	1p36.13	A22455
Doxorubicin	Approved Investigational	EPHX1	2052	upregulated	Doxorubicin results in increased expression of EPHX1 mRNA	1q42.12	A22430

Displaying entries 35876 - 35900 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability